ArsenalBio
$325.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
ArsenalBio is currently valued at $1.9B as of September 4, 2024. The company has raised a total of $630.8M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.93x, ArsenalBio has achieved a valuation that is 2.93 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
ArsenalBio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is ArsenalBio Worth in 2025?
As of 2025, ArsenalBio is valued at $1.9B, based on the company's Later Stage VC funding round in September 4, 2024. This valuation positions ArsenalBio as one of the leading private companies in the sector.
ArsenalBio Valuation History
ArsenalBio's funding history demonstrates steady growth and investor confidence.
How ArsenalBio Valuation is Determined
Private company valuations like ArsenalBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
ArsenalBio Valuation FAQs
Is ArsenalBio profitable?
ArsenalBio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does ArsenalBio's valuation compare to competitors?
ArsenalBio is valued at $1.9B, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will ArsenalBio IPO?
ArsenalBio has not announced plans for an initial public offering. Until an IPO, investors can access ArsenalBio shares through secondary market platforms.